American Century Companies’s AstraZeneca AZN Stock Holding History

American Century Companies's AZN Position: Q2 2026 in Review

American Century Companies reduced its AstraZeneca (AZN) stake by 27% in Q2 2026, selling an estimated $91.5M and leaving 1,320,358 shares worth $250M. The position accounts for 0.11% of the portfolio, ranked #151.

American Century Companies first reported a position in AZN in Q4 2019 and has held it in 27 quarters since. The position peaked at $356M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

• American Century Companies held 1,320,358 shares of AstraZeneca worth $250M as of Q2 2026.
• American Century Companies sold 486,668 AstraZeneca shares in Q2 2026, an estimated $91.5M.
• AstraZeneca made up 0.11% of American Century Companies's portfolio in Q2 2026, its #151 holding.
• American Century Companies first reported a position in AstraZeneca in Q4 2019 and has held it in 27 quarters since.
• American Century Companies's AstraZeneca position peaked at $356M in Q1 2026.
• 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.